Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entrada Therapeutics (TRDA) Gains from Investment Securities (2022 - 2025)

Entrada Therapeutics has reported Gains from Investment Securities over the past 4 years, most recently at -$93000.0 for Q4 2025.

  • Quarterly results put Gains from Investment Securities at -$93000.0 for Q4 2025, up 79.87% from a year ago — trailing twelve months through Dec 2025 was -$214000.0 (up 91.46% YoY), and the annual figure for FY2025 was -$214000.0, up 91.46%.
  • Gains from Investment Securities for Q4 2025 was -$93000.0 at Entrada Therapeutics, down from -$36000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for TRDA hit a ceiling of $65.8 million in Q4 2023 and a floor of -$2.0 million in Q2 2024.
  • Median Gains from Investment Securities over the past 4 years was -$32000.0 (2024), compared with a mean of $4.7 million.
  • Biggest five-year swings in Gains from Investment Securities: soared 80380.49% in 2023 and later tumbled 3500.0% in 2025.
  • Entrada Therapeutics' Gains from Investment Securities stood at -$82000.0 in 2022, then soared by 80380.49% to $65.8 million in 2023, then tumbled by 100.7% to -$462000.0 in 2024, then soared by 79.87% to -$93000.0 in 2025.
  • The last three reported values for Gains from Investment Securities were -$93000.0 (Q4 2025), -$36000.0 (Q3 2025), and -$40000.0 (Q2 2025) per Business Quant data.